R01 CA113859/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2006	1
2007	1
2008	3
2010	1
2011	2
2012	1
2014	2
2015	2
2024	0

1

The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.

Chen MC, Zhou B, Zhang K, Yuan YC, Un F, Hu S, Chou CM, Chen CH, Wu J, Wang Y, Liu X, Smith DL, Li H, Liu Z, Warden CD, Su L, Malkas LH, Chung YM, Hu MC, Yen Y. Chen MC, et al. Mol Pharmacol. 2015 Jun;87(6):996-1005. doi: 10.1124/mol.114.094987. Epub 2015 Mar 26. Mol Pharmacol. 2015. PMID: 25814515 Free PMC article.

2

FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage.

Chung YM, Park SH, Tsai WB, Wang SY, Ikeda MA, Berek JS, Chen DJ, Hu MC. Chung YM, et al. Nat Commun. 2012;3:1000. doi: 10.1038/ncomms2008. Nat Commun. 2012. PMID: 22893124 Free PMC article.

3

Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53.

Park SH, Lee JH, Berek JS, Hu MC. Park SH, et al. Int J Oncol. 2014 Oct;45(4):1691-8. doi: 10.3892/ijo.2014.2579. Epub 2014 Aug 4. Int J Oncol. 2014. PMID: 25096914 Free PMC article.

4

Functional interaction between FOXO3a and ATM regulates DNA damage response.

Tsai WB, Chung YM, Takahashi Y, Xu Z, Hu MC. Tsai WB, et al. Nat Cell Biol. 2008 Apr;10(4):460-7. doi: 10.1038/ncb1709. Epub 2008 Mar 16. Nat Cell Biol. 2008. PMID: 18344987 Free PMC article.

5

ATM-mediated phosphorylation of polynucleotide kinase/phosphatase is required for effective DNA double-strand break repair.

Segal-Raz H, Mass G, Baranes-Bachar K, Lerenthal Y, Wang SY, Chung YM, Ziv-Lehrman S, Ström CE, Helleday T, Hu MC, Chen DJ, Shiloh Y. Segal-Raz H, et al. EMBO Rep. 2011 Jul 1;12(7):713-9. doi: 10.1038/embor.2011.96. EMBO Rep. 2011. PMID: 21637298 Free PMC article.

6

Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks.

Moyal L, Lerenthal Y, Gana-Weisz M, Mass G, So S, Wang SY, Eppink B, Chung YM, Shalev G, Shema E, Shkedy D, Smorodinsky NI, van Vliet N, Kuster B, Mann M, Ciechanover A, Dahm-Daphi J, Kanaar R, Hu MC, Chen DJ, Oren M, Shiloh Y. Moyal L, et al. Mol Cell. 2011 Mar 4;41(5):529-42. doi: 10.1016/j.molcel.2011.02.015. Mol Cell. 2011. PMID: 21362549 Free PMC article.

7

Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation.

Hu T, Chung YM, Guan M, Ma M, Ma J, Berek JS, Hu MC. Hu T, et al. Sci Rep. 2014 Jul 24;4:5810. doi: 10.1038/srep05810. Sci Rep. 2014. PMID: 25056111 Free PMC article.

8

Inhibition of FOXO3 tumor suppressor function by betaTrCP1 through ubiquitin-mediated degradation in a tumor mouse model.

Tsai WB, Chung YM, Zou Y, Park SH, Xu Z, Nakayama K, Lin SH, Hu MC. Tsai WB, et al. PLoS One. 2010 Jul 2;5(7):e11171. doi: 10.1371/journal.pone.0011171. PLoS One. 2010. PMID: 20625400 Free PMC article.

9

Effects of Low-Dose Bisphenol A on DNA Damage and Proliferation of Breast Cells: The Role of c-Myc.

Pfeifer D, Chung YM, Hu MC. Pfeifer D, et al. Environ Health Perspect. 2015 Dec;123(12):1271-9. doi: 10.1289/ehp.1409199. Epub 2015 May 1. Environ Health Perspect. 2015. PMID: 25933419 Free PMC article.

10

Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.

Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, Li PC, Lin SH, Hu MC. Zou Y, et al. Breast Cancer Res. 2008;10(1):R21. doi: 10.1186/bcr1872. Epub 2008 Feb 29. Breast Cancer Res. 2008. PMID: 18312651 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year